---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-154021"
form_type: "8-K"
ticker: "VRTX"
cik: "0000875320"
company_name: "VERTEX PHARMACEUTICALS INC / MA"
filed_at: "2022-05-18T23:59:59+00:00"
generated_at: "2026-06-25T10:48:14.653735+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Vertex shareholders elect 11 directors, approve stock plan amendment adding 13.5M shares

## Summary
- All 11 director nominees elected, with Reshma Kewalramani receiving 218.7M votes for.
- Ratification of Ernst & Young as auditor for FY2022 passed with 177.8M for, 51.9M against.
- Advisory say-on-pay approved, 202.2M for vs 16.1M against.
- Amendment to 2013 Stock and Option Plan adding 13.5M shares authorized for issuance approved.

## SEC filing metadata
- accession: 0001193125-22-154021
- form_type: 8-K
- ticker: VRTX
- cik: 0000875320
- company_name: VERTEX PHARMACEUTICALS INC / MA
- filed_at: 2022-05-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/875320/000119312522154021/0001193125-22-154021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/875320/000119312522154021/d272923d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-154021
- JSON: https://secwatch.observer/filing/0001193125-22-154021.json
- Plain text: https://secwatch.observer/filing/0001193125-22-154021.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.